BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 30767744)

  • 1. In Silico Inhibition of BACE-1 by Selective Phytochemicals as Novel Potential Inhibitors: Molecular Docking and DFT Studies.
    Arif N; Subhani A; Hussain W; Rasool N
    Curr Drug Discov Technol; 2020; 17(3):397-411. PubMed ID: 30767744
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Computer-aided analysis of phytochemicals as potential dengue virus inhibitors based on molecular docking, ADMET and DFT studies.
    Qaddir I; Rasool N; Hussain W; Mahmood S
    J Vector Borne Dis; 2017; 54(3):255-262. PubMed ID: 29097641
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The potential of natural product vs neurodegenerative disorders: In silico study of artoflavanocoumarin as BACE-1 inhibitor.
    Razzaghi-Asl N; Karimi A; Ebadi A
    Comput Biol Chem; 2018 Dec; 77():307-317. PubMed ID: 30445338
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Repurposing of phyto-ligand molecules from the honey bee products for Alzheimer's disease as novel inhibitors of BACE-1: small molecule bioinformatics strategies as amyloid-based therapy.
    Nisa N; Rasmita B; Arati C; Uditraj C; Siddhartha R; Dinata R; Bhanushree B; Bidanchi RM; Manikandan B; Laskar SA; Abinash G; Pori B; Roy VK; Gurusubramanian G
    Environ Sci Pollut Res Int; 2023 Apr; 30(17):51143-51169. PubMed ID: 36808033
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dynamic Simulation, Docking and DFT Studies Applied to a Set of Anti-Acetylcholinesterase Inhibitors in the enzyme β-Secretase (BACE-1): An Important Therapeutic Target in Alzheimer`s disease.
    Silva-Junior EF; Barcellos Franca PH; Quintans-Junior LJ; Mendonca-Junior FJB; Scotti L; Scotti MT; de Aquino TM; de Araujo-Junior JX
    Curr Comput Aided Drug Des; 2017 Nov; 13(4):266-274. PubMed ID: 28382866
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Investigation of naphthofuran moiety as potential dual inhibitor against BACE-1 and GSK-3β: molecular dynamics simulations, binding energy, and network analysis to identify first-in-class dual inhibitors against Alzheimer's disease.
    Kumar A; Srivastava G; Srivastava S; Verma S; Negi AS; Sharma A
    J Mol Model; 2017 Aug; 23(8):239. PubMed ID: 28741112
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of potential lead compounds against BACE1 through in-silico screening of phytochemicals of Medhya rasayana plants for Alzheimer's disease management.
    Nadh AG; Revikumar A; Sudhakaran PR; Nair AS
    Comput Biol Med; 2022 Jun; 145():105422. PubMed ID: 35354103
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design and synthesis of novel 3,5-bis-N-(aryl/heteroaryl) carbamoyl-4-aryl-1,4-dihydropyridines as small molecule BACE-1 inhibitors.
    Razzaghi-Asl N; Firuzi O; Hemmateenejad B; Javidnia K; Edraki N; Miri R
    Bioorg Med Chem; 2013 Nov; 21(22):6893-909. PubMed ID: 24113238
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Semi-synthetic isoflavones as BACE-1 inhibitors against Alzheimer's disease.
    Ribaudo G; Coghi P; Zanforlin E; Law BYK; Wu YYJ; Han Y; Qiu AC; Qu YQ; Zagotto G; Wong VKW
    Bioorg Chem; 2019 Jun; 87():474-483. PubMed ID: 30927588
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In-silico Studies and Biological Activity of Potential BACE-1 Inhibitors.
    Arya R; Paliwal S; Gupta SP; Sharma S; Madan K; Mishra A; Verma K; Chauhan N
    Comb Chem High Throughput Screen; 2021; 24(5):729-736. PubMed ID: 32957879
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A physicochemical descriptor based method for effective and rapid screening of dual inhibitors against BACE-1 and GSK-3β as targets for Alzheimer's disease.
    Kumar A; Srivastava G; Sharma A
    Comput Biol Chem; 2017 Dec; 71():1-9. PubMed ID: 28950235
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unveiling a novel transient druggable pocket in BACE-1 through molecular simulations: Conformational analysis and binding mode of multisite inhibitors.
    Di Pietro O; Juárez-Jiménez J; Muñoz-Torrero D; Laughton CA; Luque FJ
    PLoS One; 2017; 12(5):e0177683. PubMed ID: 28505196
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potent BACE-1 inhibitor design using pharmacophore modeling, in silico screening and molecular docking studies.
    John S; Thangapandian S; Sakkiah S; Lee KW
    BMC Bioinformatics; 2011 Feb; 12 Suppl 1(Suppl 1):S28. PubMed ID: 21342558
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Docking, molecular dynamics, binding energy-MM-PBSA studies of naphthofuran derivatives to identify potential dual inhibitors against BACE-1 and GSK-3β.
    Kumar A; Srivastava G; Negi AS; Sharma A
    J Biomol Struct Dyn; 2019 Feb; 37(2):275-290. PubMed ID: 29310523
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural bioinformatics-based identification of EGFR inhibitor gefitinib as a putative lead compound for BACE.
    Niu M; Hu J; Wu S; Xiaoe Z; Xu H; Zhang Y; Zhang J; Yang Y
    Chem Biol Drug Des; 2014 Jan; 83(1):81-8. PubMed ID: 24516878
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design, Synthesis and Evaluation of 2,4,6-substituted Pyrimidine Derivatives as BACE-1 Inhibitor: Plausible Lead for Alzheimer's Disease.
    Jain P; Wadhwa PK; Jadhav HR
    Med Chem; 2021; 17(10):1194-1206. PubMed ID: 33349218
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Flavonols and flavones as BACE-1 inhibitors: structure-activity relationship in cell-free, cell-based and in silico studies reveal novel pharmacophore features.
    Shimmyo Y; Kihara T; Akaike A; Niidome T; Sugimoto H
    Biochim Biophys Acta; 2008 May; 1780(5):819-25. PubMed ID: 18295609
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibitory activities of major anthraquinones and other constituents from Cassia obtusifolia against β-secretase and cholinesterases.
    Jung HA; Ali MY; Jung HJ; Jeong HO; Chung HY; Choi JS
    J Ethnopharmacol; 2016 Sep; 191():152-160. PubMed ID: 27321278
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Concatenation of molecular docking and molecular simulation of BACE-1, γ-secretase targeted ligands: in pursuit of Alzheimer's treatment.
    Jabir NR; Rehman MT; Alsolami K; Shakil S; Zughaibi TA; Alserihi RF; Khan MS; AlAjmi MF; Tabrez S
    Ann Med; 2021 Dec; 53(1):2332-2344. PubMed ID: 34889159
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Screening and Elucidation of Selected Natural Compounds for Anti- Alzheimer's Potential Targeting BACE-1 Enzyme: A Case Computational Study.
    Ahmad SS; Akhtar S; Danish Rizvi SM; Kamal MA; Sayeed U; Khan MKA; Siddiqui MH; Arif JM
    Curr Comput Aided Drug Des; 2017 Nov; 13(4):311-318. PubMed ID: 28413992
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.